Prof. Dr. Peter Philippsen, Emeritus 1978 - 2011 | Professor of Molecular Microbiology Peter Philippsen first came to the Biozentrum as an Assistant Professor in 1978. Prior to this, he spent several years in postdoctoral…

Central Mechanical Workshop The requirements for lab apparatus are as diverse as the research topics at the Biozentrum. For this reason, you will find a whole range of non-commercially available devices and installations…

Prof. Dr. Thomas Kiefhaber 1993 - 2007 | Professor of Biophysical Chemistry Thomas Kiefhaber studied and graduated with a doctorate at the Universities of Regensburg and Bayreuth in the field of biophysics. From 1991 until…

Prof. Dr. Joachim Seelig, Emeritus 1972 - 2012 | Professor of Structural Biology Since 1972 Joachim Seelig (*1942, † 2024) carried out research, first, as Assistant Professor and since 1982 as Full Professor of Structural…

CV of Prof. Dr. David Brückner ORCID 0000-0001-7205-2975 Google Scholar Google Scholar Nationality: German Positions: Since 2025 Assistant Professor of Theoretical Biophysics, Biozentrum of the University of Basel, Basel,…

D4: Molecular and Cellular Structural Biology III – 17002 (2 hrs/week; 2 CP; Spring 2026) Timm Maier This lecture series leads towards the understanding of the structural and functional aspects of biological membranes by…

Exploring new horizons November 2016 Christian Sengstag had never imagined that he would one day do anything other than research. But then he was presented with a fait accompli: His research institute was to be closed down.…

Biozentrum Discovery Seminars Biozentrum Discovery (BZD) is a seminar series, which alternates between talks by renowned guest speakers and seminars given by graduate students and postdocs from the Biozentrum. The seminars…

T3 Pharmaceuticals (“T3 Pharma”) was founded in 2015 as a spin-off of the Biozentrum of the University of Basel. The company focuses on bacterial therapies for the treatment of solid tumors. The Basel-based biotech company’s…

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the treatment of diabetes is too low to inhibit cancer growth. The…